Analysis: Reports of drug side effects increase fivefold in 12 years
More than 1 million reports of drug side effects were filed with the U.S. Food and Drug Administration in 2015, a fivefold increase since 20
top of page
Search
STAT News, Renee M. Landers
Mar 20, 20172 min read
Scott Gottlieb’s fervor for deregulation could harm patients
The Senate will soon begin the process of considering President Trump’s nomination of Dr. Scott Gottlieb, who has close professional and fin
6 views0 comments
The Cancer Letter, Matthew Bin Han Ong
Feb 27, 20171 min read
GAO: Power morcellation is a unique case study in patient harm
Power morcellators likely contributed to injury and deaths of hundreds of women, according to a new study by the Government Accountability O
20 views0 comments
National Public Radio, Richard Harris
Feb 27, 20171 min read
Advice from patients on a study's design makes for better science
Robert Comis describes the success of the NCI-MATCH trial and involving patient advocates in the process.
4 views0 comments
sg0251
Feb 24, 20172 min read
The USA Patient Network Asks Senators to Oppose the Right to Try Act
The USA Patient Network outlines the risks of supporting the Right to Try Act and asks senators to withdraw their support.
23 views0 comments
Our Bodies Our Selves, Amie Newman
Feb 24, 20172 min read
Trump’s plan for the FDA will make patients less safe
Read why President Trump's plan to streamline the FDA approval process will make patients less safe and will cause their health to suffe
22 views0 comments
sg0251
Feb 22, 20172 min read
USA Patient Network Thanks Senators For Not Co-Sponsoring Right to Try Act
The USA Patient Network thanks senators for not co-sponsoring the Trickett Wendler Right to Try Act because it would put patients in harm’s
33 views0 comments
Stat, Danielle Ofri
Feb 16, 20171 min read
The Joy of Hearing Patients Out
Read what happened when one doctor took the time to sit back and let their patients talk about their health uninterrupted.
5 views0 comments
Kaiser Health News, Liz Szabo
Feb 9, 20171 min read
Amid flurry of new cancer drugs, how many offer real benefits?
President Diana Zuckerman is cited in an article that discusses the effectiveness of recently approved oncology drugs that seem to offer lit
6 views0 comments
The Washington Post, Carolyn Y Johnson
Feb 2, 20171 min read
Trump calls for lower drug prices, fewer regulations in meeting with pharmaceutical executives
In a meeting with top pharmaceutical executives, President Trump offers no specific policies but emphasizes the need for lowering drug price
16 views0 comments
The New York Times, Katie Thomas
Feb 1, 20171 min read
Trump vows to ease rules for drug makers, but zeros in on prices
President Trump promised some of the nation’s top drug company executives in a meeting at the White House on Tuesday that he would slash reg
10 views0 comments
Natalya Estrada, Times Standard
Jan 28, 20172 min read
ACA repeal talk sparks fears among those with pre-existing conditions
Most health insurance companies also treated individual patients with pre-existing conditions differently than those that bought health insu
2 views0 comments
Kaiser Health News
Jan 23, 20171 min read
Trump’s HHS nominee prioritized profits over patients
As Cabinet nominee Tom Price faces a Senate confirmation hearing Tuesday, a newly released trove of documents sheds further light on how he
11 views0 comments
Regulatory Affairs Professionals Society
Jan 13, 20171 min read
Analysis: Longer Review Times Associated With Fewer Adverse Events for High-Risk Heart Devices
A new analysis finds longer regulatory review times for high-risk cardiovascular medical devices to be associated with fewer adverse event r
9 views0 comments
LA Times, Michael Hiltzik
Jan 10, 20171 min read
To appease a patient lobby, did the FDA approve a $300,000 drug that doesn't work?
The evidence supporting Exondys 51, an FDA approved drug meant to treat Duchenne muscular dystrophy, is too thin for a drug that costs $300,
16 views0 comments
Project on Government Oversight
Jan 10, 20171 min read
FDA Depends on Industry Funding; Money Comes with “Strings Attached”
The Food and Drug Administration's approval process is confusing, complicated and intertwined with lobbyists and top drug company execut
43 views0 comments
sg0251
Jan 6, 20173 min read
Comments of members of the USA Patient Network on Establishment of the Patient and Care-Partner Conn
Our comments are focused on the issues of inclusion and barriers to participation, but also on the broader issue of making sure that patient
14 views0 comments
Consumer Reports, Teresa Carr
Jan 4, 20171 min read
Off-Label Use: Should Drugs Do Double Duty?
Doctors often prescribe drugs "off label", meaning for purposes it wasn't approved for by the FDA. Most don't tell their p
11 views0 comments
sg0251
Dec 5, 20163 min read
USA Patient Network Letter to Senate asking to delay and fix 21st Century Cures Act
The USA Patient Network respectfully and strongly urges senators to vote against the 21st Century Cures Act this week, and instead insist th
88 views0 comments
Reuters Health, Andrew M. Seaman
Dec 5, 20161 min read
Cancer drugs may remain approved despite lack of benefit
In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies sho
9 views0 comments
bottom of page